Insulet Corporation · 1 day ago
Sr FP&A Analyst (Hybrid - Acton, MA)
Insulet Corporation is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions. They are seeking a Senior Analyst FP&A, Procurement & Capital to provide financial insights, manage budgets, and drive cost optimization across sourcing and capital investment initiatives.
Health CareMedicalMedical Device
Responsibilities
Partner with Strategic Sourcing and Procurement teams to analyze supplier spend, cost savings initiatives, and contract performance
Develop and maintain dashboards and reports to track procurement KPIs (e.g., cost savings, supplier performance, category spend)
Support vendor negotiations with financial models and total cost of ownership (TCO) analysis
Monitor and report on purchase price variances (PPV) and material cost trends
Support CBOM sourcing initiatives and setting up alternative regional CBOMs
Collaborate with Engineering and Operations to evaluate and prioritize capital investment proposals
Review ROI analysis for capital projects, including NPV, IRR, and payback period
Track and report capital spending against budget, highlighting variances and risks
Ensure compliance with capital approval policies and support the capital appropriation request (CAR) process
Develop and maintain detailed cash flow forecasts related to capital projects and procurement activities to include multi-year planning as well as quarterly for next 24 months
Partner with Treasury and FP&A teams to align CAPEX cash flow projections with broader liquidity planning
Monitor actual cash outflows versus forecast, and provide variance analysis with actionable insights
Identify timing risks and opportunities in capital deployment to optimize working capital and funding strategies
Support annual budgeting, quarterly forecasting, and long-range planning for procurement and capital spending
Prepare monthly and quarterly financial reports with variance analysis and strategic recommendations
Identify opportunities for cost reduction, process improvement, and capital efficiency
Present findings and recommendations to senior leadership and cross-functional stakeholders
Qualification
Required
Bachelor's degree; Degree in Finance, Accounting, Economics, or related field preferred (MBA or CPA/CMA preferred)
3+ years of progressive experience in financial analysis, preferably in a manufacturing, industrial, or capital-intensive environment
Strong understanding of procurement processes, CapEx planning, and financial modeling
Experience with cash flow forecasting and liquidity planning
Advanced Excel skills and proficiency with financial systems (e.g., SAP, SAC, Power BI, Oracle, Hyperion)
Excellent communication, collaboration, and presentation skills
Ability to manage multiple priorities and deliver high-quality work under tight deadlines
Preferred
Experience supporting capital projects, vendor negotiations, or strategic sourcing initiatives
Familiarity with project accounting, fixed asset management, and treasury collaboration
Strong business acumen and ability to influence cross-functional teams
Benefits
Medical, dental, and vision insurance
401(k) with company match
Paid time off (PTO)
And additional employee wellness programs
Company
Insulet Corporation
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform.
H1B Sponsorship
Insulet Corporation has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (58)
2024 (43)
2023 (19)
2022 (33)
2021 (41)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$629.5MKey Investors
DeerfieldOrbiMedAlta Partners
2025-03-18Post Ipo Debt· $450M
2009-03-16Post Ipo Debt· $60M
2007-05-15IPO
Leadership Team
Recent News
2025-12-20
2025-12-17
Company data provided by crunchbase